Jay Mohr is a General Partner at NYBC Ventures and Executive Vice President at NYBCe, with over 30 years in biopharma leadership. He co-founded several companies and holds board roles in life sciences firms.
At firms with a similar stage, sector and check size.
One email when Jay's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJay Mohr is a General Partner at NYBC Ventures and Executive Vice President at NYBCe, with over 30 years in biopharma leadership. He co-founded several companies and holds board roles in life sciences firms.
NYBC Ventures has not reported a check size. It invests at seed, series a, series b.
A warm intro from a founder NYBC Ventures backed works best.
senior commercial role at Schering-Plough; senior commercial role at Serono; Chief Operating and Business Officer at AZTherapies; Schering-Plough; Serono; Executive Vice President, Chief Business Officer at New York Blood Center Enterprises.
Last updated 2026-10-15. Is this you? Ask for a correction.